Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.02), $0.58 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $17.32 million versus the consensus estimate of $18.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.